Covered recipient · General Payments record
NOLAN D ULRICH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$1,436.57
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $310.48 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $73.50 | 5 |
| ABBVIE INC. | $54.36 | 3 |
| Novo Nordisk AS | $38.04 | 2 |
| Acerta Pharma LLC | $37.20 | 2 |
| PFIZER INC. | $31.56 | 2 |
| Axsome Therapeutics, Inc. | $21.87 | 1 |
| DEXCOM, INC. | $19.51 | 1 |
| Sumitomo Pharma America, Inc. | $18.21 | 1 |
| Ardelyx, Inc. | $16.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.27 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106258994 | CMS |
| ABBVIE INC. | $19.23 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106258996 | CMS |
| ABBVIE INC. | $14.86 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106258998 | CMS |
| Ardelyx, Inc. | $16.23 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146712093 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.86 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104298662 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.34 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105395264 | CMS |
| Axsome Therapeutics, Inc. | $21.87 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148309184 | CMS |
| Dexcom, Inc. | $19.51 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153326143 | CMS |
| GlaxoSmithKline, LLC. | $13.72 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116533154 | CMS |
| GlaxoSmithKline, LLC. | $13.72 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116581643 | CMS |
| GlaxoSmithKline, LLC. | $17.78 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116555383 | CMS |
| GlaxoSmithKline, LLC. | $14.56 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116733866 | CMS |
| GlaxoSmithKline, LLC. | $13.72 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116233132 | CMS |
| Novo Nordisk Inc | $21.68 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096685938 | CMS |
| Novo Nordisk Inc | $16.36 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097323600 | CMS |
| PFIZER INC. | $14.79 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131734334 | CMS |
| PFIZER INC. | $16.77 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132010882 | CMS |
| Sumitomo Pharma America, Inc. | $18.21 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148930394 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.